Back

prof. dr. R.E.G. Schutgens

prof. dr. R.E.G. Schutgens

Full Professor
prof. dr. R.E.G. Schutgens
  • Hematology/Van Creveldclinic

Biography

Biography

Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Side Activities

Advisory Board Member Horizonscan geneesmiddelen ZonMW

Scientific Editor HemaSphere (the EHA journal)

Co-owner general practice 'Huisartsenpraktijk Voordorp'

Research Output (254)

Proof of concept and feasibility of a blended physiotherapy intervention for persons with haemophilic arthropathy

Timmer Merel A, Kuijlaars Isolde A R, Kloek Corelien, de Kleijn Piet, Schutgens Roger E G, Veenhof Cindy, Pisters Martijn F 17 Nov 2022, In: Haemophilia. 29 , p. 290-307 18 p.

Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling

Janssen Alexander, Hoogendoorn Mark, Cnossen Marjon H., Mathôt Ron A.A., Cnossen M. H., Reitsma S. H., Leebeek F. W.G., Mathôt R. A.A., Fijnvandraat K., Coppens M., Meijer K., Schols S. E.M., Eikenboom H. C.J., Schutgens R. E.G., Beckers E. A.M., Ypma P., Kruip M. J.H.A., Polinder S., Tamminga R. Y.J., Brons P., Fischer K., van Galen K. P.M., Heubel-Moenen F. C.J.I., Nieuwenhuizen L., Driessens M. H.E., van Vliet I., Lock J., Hazendonk H. C.A.M., van Moort I., Heijdra J. M., Goedhart M. H.J., Al Arashi W., Preijers T., de Jager N. C.B., Bukkems L. H., Cloesmeijer M. E., Janssen A., Collins P. W., Liesner R., Chowdary P., Millar C. M., Hart D., Keeling D., Aug 2022, In: CPT: Pharmacometrics and Systems Pharmacology. 11 , p. 1100-1110 11 p.

Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units:A retrospective cohort study

Noordermeer Tessa, Schutgens Roger E G, Visser Chantal, Rademaker Emma, de Maat Moniek P M, Jansen A J Gerard, Limper Maarten, Cremer Olaf L, Kruip Marieke J H A, Endeman Henrik, Maas Coen, de Laat Bas, Urbanus Rolf T, Aug 2022, In: Research and practice in thrombosis and haemostasis. 6

Desmopressin testing in von Willebrand disease:Lowering the burden

Heijdra Jessica M., Atiq Ferdows, Al Arashi Wala, Kieboom Quincy, Wuijster Esmee, Meijer Karina, Kruip Marieke J.H.A., Leebeek Frank W.G., Cnossen Marjon H., , Fijnvandraat K., Mathôt R. A.A., Polinder S., Coppens M., Tamminga R. Y.J., Meijer K., Laros-van Gorkom B. A.P., Brons P., Schols S. E.M., van der Meer F. J.M., Eikenboom H. C.J., Schutgens R. E.G., Fischer K., Heubel-Moenen F., Nieuwenhuizen L., Ypma P., Driessens M. H.E., Zwaan C. M., van Vliet I., Collins P. W., Liesner R., Chowdary P., Keeling D., Lock J., Hazendonk H. C.A.M., van Moort I., Preijers T., de Jager N. C.B., Goedhart M. C.H.J., Bukkems L. H., Cloesmeijer M. E., Janssen A. Aug 2022, In: Research and practice in thrombosis and haemostasis. 6

The fear for adverse bleeding and cardiovascular events in hemophilia patients using (non-)selective non-steroidal anti-inflammatory drugs:A systematic review reporting on safety

van Bergen E. D.P., Monnikhof M., Lafeber F. P.J.G., Schutgens R. E.G., Mastbergen S. C., van Vulpen L. F.D. 24 Jun 2022, In: Blood Reviews. 56

Menstrual problems in chronic immune thrombocytopenia:A monthly challenge - a cohort study and review

van Dijk Wobke E M, Punt Marieke C, van Galen Karin P M, van Leeuwen Jeanette, Lely A Titia, Schutgens Roger E G 3 Jun 2022, In: British Journal of Haematology. 198 , p. 753-764 12 p.

SYMPHONY consortium:Orchestrating personalized treatment for patients with bleeding disorders

Cnossen Marjon H, van Moort Iris, Reitsma Simone H, de Maat Moniek P M, Schutgens Roger E G, Urbanus Rolf T, Lingsma Hester F, Mathot Ron A A, Gouw Samantha C, Meijer Karina, Bredenoord Annelien L, van der Graaf Rieke, Fijnvandraat Karin, Meijer Alexander B, van den Akker Emile, Bierings Ruben, Eikenboom Jeroen C J, van den Biggelaar Maartje, de Haas Masja, Voorberg Jan, Leebeek Frank W G, 2 Jun 2022, In: Journal of thrombosis and haemostasis : JTH. 20 , p. 2001-2011 11 p.

Gene Therapy for Hemophilia A:How Long Will It Last?

Schutgens Roger E G Jun 2022, In: HemaSphere. 6 , p. e720

Proton pump inhibition for secondary hemochromatosis in hereditary anemia:a phase III placebo-controlled randomized cross-over clinical trial.

van Vuren Annelies, Kerkhoffs Jean Louis, Schols Saskia, Rijneveld Anita, Nur Erfan, Peereboom Dore, Gandon Yves, Welsing Paco, van Wijk Richard, Schutgens Roger, van Solinge Wouter, Marx Joannes, Leiner Tim, Biemond Bart, van Beers Eduard 26 Apr 2022, In: American Journal of Hematology. 97 , p. 924-932 9 p.

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia

Versloot Olav, Iserman Emma, Chelle Pierre, Germini Federico, Edginton Andrea N, Schutgens Roger E G, Iorio Alfonso, Fischer Kathelijn 21 Apr 2022, In: HemaSphere. 6 , p. 1-7

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet